Retreatment with yttrium-90 ibritumomab tiuxetan in patients with B-cell non-Hodgkin's lymphoma.
Shah J, Wang W, Harrough VD, Saville W, Meredith R, Shen S, Mueh J, Lister J, Jasthy S, Maggass G, McKay C, Krumdieck R, Tharp M, Winter C, Gregory S, Buchholz W, Awasthi S, Jacobs S, Chung H, Egner J, Lobuglio AF, Forero A.
Shah J, et al. Among authors: lister j.
Leuk Lymphoma. 2007 Sep;48(9):1736-44. doi: 10.1080/10428190701528517.
Leuk Lymphoma. 2007.
PMID: 17786709